Second Irregularity In NSABP Data Found; Fisher Takes Leave As Group’s Chairman
In Brief: Ross Retires From Bristol-Myers, Forms Own Consulting Service; Obey Wins Key Post
NCI Promises Strong Monitoring Process Visco Calls For Independent Review; Rep. Dingell Plans Hearing April 13
Biotech Organization Endorses Measures On Orphan Drug Act
Salick Signs contract for Fixed-Price Oncology Services
DCE Advisors OK RFAs In Occupational Cancer, H. Pylori
Trending Stories
- ACOG says it will no longer accept federal funding
- Gardiner Harris, acclaimed health care and pharma journalist, on his New York Times bestselling book
- Pediatric cancer research cut from spending legislation at last minute
Republicans quietly removed hard-won pediatric cancer bills - Knight Cancer Institute receives record-setting $2B gift from the Knights—and self-governance within OHSU
Brian Druker returns to executive role as president of the new Knight Cancer Group - ANCHOR trial shows that treatment of anal high-grade squamous intraepithelial lesions prevents anal cancer in people with HIV
- “If I’m not dying, I better go live.” Christy Erickson’s cancer diagnosis led to life as a motorcyclist and strongman competitor